1. Home
  2. ITOS vs FBIZ Comparison

ITOS vs FBIZ Comparison

Compare ITOS & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FBIZ
  • Stock Information
  • Founded
  • ITOS 2011
  • FBIZ 1909
  • Country
  • ITOS United States
  • FBIZ United States
  • Employees
  • ITOS N/A
  • FBIZ N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FBIZ Major Banks
  • Sector
  • ITOS Health Care
  • FBIZ Finance
  • Exchange
  • ITOS Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • ITOS 450.9M
  • FBIZ 390.3M
  • IPO Year
  • ITOS 2020
  • FBIZ N/A
  • Fundamental
  • Price
  • ITOS N/A
  • FBIZ $52.01
  • Analyst Decision
  • ITOS Hold
  • FBIZ Buy
  • Analyst Count
  • ITOS 6
  • FBIZ 3
  • Target Price
  • ITOS $10.40
  • FBIZ $58.67
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • FBIZ 29.8K
  • Earning Date
  • ITOS 08-06-2025
  • FBIZ 10-23-2025
  • Dividend Yield
  • ITOS N/A
  • FBIZ 2.23%
  • EPS Growth
  • ITOS N/A
  • FBIZ 22.50
  • EPS
  • ITOS N/A
  • FBIZ 5.60
  • Revenue
  • ITOS N/A
  • FBIZ $150,952,000.00
  • Revenue This Year
  • ITOS N/A
  • FBIZ $17.98
  • Revenue Next Year
  • ITOS N/A
  • FBIZ $8.26
  • P/E Ratio
  • ITOS N/A
  • FBIZ $9.29
  • Revenue Growth
  • ITOS 177.89
  • FBIZ 8.24
  • 52 Week Low
  • ITOS $4.80
  • FBIZ $41.31
  • 52 Week High
  • ITOS $17.63
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 1.63
  • FBIZ 58.70
  • Support Level
  • ITOS $10.10
  • FBIZ $50.93
  • Resistance Level
  • ITOS $10.17
  • FBIZ $52.88
  • Average True Range (ATR)
  • ITOS 0.03
  • FBIZ 1.00
  • MACD
  • ITOS -1.20
  • FBIZ 0.21
  • Stochastic Oscillator
  • ITOS 0.00
  • FBIZ 67.77

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: